Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people >65 years of age: A post hoc analysis of data from the SOFIA study-Reference-Cited by-同舟云学术

Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people >65 years of age: A post hoc analysis of data from the SOFIA study

Published:2014-04-03 Issue:5 Volume:34 Page:438-443
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourol. Urodynam.

Author:

Wagg Adrian¹,Darekar Amanda²,Arumi Daniel³,Khullar Vik⁴,Oelke Matthias⁵^ORCID

Affiliation:

1. University of Alberta; Edmonton Alberta Canada

2. Pfizer Ltd; Walton Oaks United Kingdom

3. Pfizer Europe; Madrid Spain

4. St Mary's Hospital; Imperial College; London United Kingdom

5. Hannover Medical School; Hannover Germany

Funder

Pfizer

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nau.22603/fullpdf

Reference21 articles.

1. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

2. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Neurourol Urodyn,2010

3. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study;Irwin;Eur Urol,2006

4. Flexible-dose fesoterodine in elderly adults with overactive bladder: Results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial;Wagg;J Am Geriatr Soc,2013

5. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: The SENIOR study;Wagg;Eur Urol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

2. Treat bladder dysfunction in older patients with established agents, but botulinum toxin type A may have a role;Drugs & Therapy Perspectives;2023-03-21

3. Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the Eudra-Vigilance Database;Minerva Urology and Nephrology;2023-01

4. Chronic bladder diseases: overactive bladder and interstitial cystitis/bladder pain syndrome;Journal of the Korean Medical Association;2021-11-10

5. What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine;Neurourology and Urodynamics;2021-05-26